Strength
37.5 mg/1
Manufacturer
AvPAKNDC
50268087315
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212277On Market Since
2/25/2025
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has been published 46 times since Aug 13, 2025, and over the history we have for it it has declined 7.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0850 per EA |
|---|---|
| All-time high | $0.0924 (Sep 10, 2025) |
| All-time low | $0.0850 (Jun 17, 2026) |
| 52-week high | $0.0924 |
| 52-week low | $0.0850 |
| Median price | $0.0897 |
| Average price | $0.0889 |
| Largest weekly change | -3.1% (Feb 18, 2026) |
| Weeks tracked | 46 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 37.5 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 37.5 MG CAP, manufactured by AvPAK, is $0.0850 per EA (NDC 50268087315), effective Jun 24, 2026.
How has the price of VENLAFAXINE HCL ER 37.5 MG CAP changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has declined 7.2%. It has been tracked across 46 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 37.5 MG CAP?
Since Aug 13, 2025, the NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has ranged from a low of $0.0850 (Jun 17, 2026) to a high of $0.0924 (Sep 10, 2025), with a median of $0.0897 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 37.5 MG CAP?
Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, VENLAFAXINE HCL 37.5 MG TABLET, is $0.0795 per EA — about 6% below VENLAFAXINE HCL ER 37.5 MG CAP.
Who manufactures VENLAFAXINE HCL ER 37.5 MG CAP?
VENLAFAXINE HCL ER 37.5 MG CAP (NDC 50268087315) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification